Literature DB >> 9371844

Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: role of inactivation.

S Hering1, S Aczél, R L Kraus, S Berjukow, J Striessnig, E N Timin.   

Abstract

The role of channel inactivation in the molecular mechanism of calcium (Ca2+) channel block by phenylalkylamines (PAA) was analyzed by designing mutant Ca2+ channels that carry the high affinity determinants of the PAA receptor site [Hockerman, G. H., Johnson, B. D., Scheuer, T., and Catterall, W. A. (1995) J. Biol. Chem. 270, 22119-22122] but inactivate at different rates. Use-dependent block by PAAs was studied after expressing the mutant Ca2+ channels in Xenopus oocytes. Substitution of single putative pore-orientated amino acids in segment IIIS6 by alanine (F-1499-A, F-1500-A, F-1510-A, I-1514-A, and F-1515-A) gradually slowed channel inactivation and simultaneously reduced inhibition of barium currents (I(Ba)) by (-)D600 upon depolarization by 100 ms steps at 0.1 Hz. This apparent reduction in drug sensitivity was only evident if test pulses were applied at a low frequency of 0.1 Hz and almost disappeared at the frequency of 1 Hz. (-)D600 slowed I(Ba) recovery after maintained membrane depolarization (1-3 sec) to a comparable extent in all channel constructs. A drug-induced delay in the onset of I(Ba) recovery from inactivation suggests that PAAs promote the transition to a deep inactivated channel conformation. These findings indicate that apparent PAA sensitivity of Ca2+ channels is not only defined by drug interaction with its receptor site but also crucially dependent on intrinsic gating properties of the channel molecule. A molecular model for PAA-Ca2+ channel interaction that accounts for the relationship between drug induced inactivation and channel block by PAA is proposed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371844      PMCID: PMC24307          DOI: 10.1073/pnas.94.24.13323

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

Review 1.  Receptor sites for Ca2+ channel antagonists.

Authors:  W A Catterall; J Striessnig
Journal:  Trends Pharmacol Sci       Date:  1992-06       Impact factor: 14.819

2.  Primary structure and functional expression from complementary DNA of a brain calcium channel.

Authors:  Y Mori; T Friedrich; M S Kim; A Mikami; J Nakai; P Ruth; E Bosse; F Hofmann; V Flockerzi; T Furuichi
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

3.  Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels.

Authors:  G H Hockerman; B D Johnson; T Scheuer; W A Catterall
Journal:  J Biol Chem       Date:  1995-09-22       Impact factor: 5.157

4.  The block of the expressed L-type calcium channel is modulated by the beta 3 subunit.

Authors:  L Lacinová; A Ludwig; E Bosse; V Flockerzi; F Hofmann
Journal:  FEBS Lett       Date:  1995-10-09       Impact factor: 4.124

5.  Molecular determinants of voltage-dependent inactivation in calcium channels.

Authors:  J F Zhang; P T Ellinor; R W Aldrich; R W Tsien
Journal:  Nature       Date:  1994-11-03       Impact factor: 49.962

6.  Ultra-slow voltage-dependent inactivation of the calcium current in guinea-pig and ferret ventricular myocytes.

Authors:  M R Boyett; H Honjo; S M Harrison; W J Zang; M S Kirby
Journal:  Pflugers Arch       Date:  1994-08       Impact factor: 3.657

7.  The benzazepine/benzothiazepine binding domain of the cardiac L-type Ca2+ channel is accessible only from the extracellular side.

Authors:  K Seydl; D Kimball; H Schindler; C Romanin
Journal:  Pflugers Arch       Date:  1993-09       Impact factor: 3.657

8.  Extracellular localization of the benzothiazepine binding domain of L-type Ca2+ channels.

Authors:  S Hering; A Savchenko; C Strübing; M Lakitsch; J Striessnig
Journal:  Mol Pharmacol       Date:  1993-05       Impact factor: 4.436

9.  Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels.

Authors:  M Grabner; Z Wang; S Hering; J Striessnig; H Glossmann
Journal:  Neuron       Date:  1996-01       Impact factor: 17.173

10.  Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calcium.

Authors:  R S Kass; J P Arena; S Chin
Journal:  J Gen Physiol       Date:  1991-07       Impact factor: 4.086

View more
  18 in total

Review 1.  Molecular determinants of inactivation in voltage-gated Ca2+ channels.

Authors:  S Hering; S Berjukow; S Sokolov; R Marksteiner; R G Weiss; R Kraus; E N Timin
Journal:  J Physiol       Date:  2000-10-15       Impact factor: 5.182

2.  Inactivation determinants in segment IIIS6 of Ca(v)3.1.

Authors:  R Marksteiner; P Schurr; S Berjukow; E Margreiter; E Perez-Reyes; S Hering
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

3.  Modulation of slow inactivation in class A Ca2+ channels by beta-subunits.

Authors:  S Sokolov; R G Weiss; E N Timin; S Hering
Journal:  J Physiol       Date:  2000-09-15       Impact factor: 5.182

4.  Block of the lymphocyte K(+) channel mKv1.3 by the phenylalkylamine verapamil: kinetic aspects of block and disruption of accumulation of block by a single point mutation.

Authors:  R J Röbe; S Grissmer
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 5.  The L-type calcium channel in the heart: the beat goes on.

Authors:  Ilona Bodi; Gabor Mikala; Sheryl E Koch; Shahab A Akhter; Arnold Schwartz
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

6.  Ca2+ channel-sarcoplasmic reticulum coupling: a mechanism of arterial myocyte contraction without Ca2+ influx.

Authors:  Alberto del Valle-Rodríguez; José López-Barneo; Juan Ureña
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

7.  Inactivation determinant in the I-II loop of the Ca2+ channel alpha1-subunit and beta-subunit interaction affect sensitivity for the phenylalkylamine (-)gallopamil.

Authors:  S Sokolov; R G Weiss; B Kurka; F Gapp; S Hering
Journal:  J Physiol       Date:  1999-09-01       Impact factor: 5.182

Review 8.  Molecular basis of drug interaction with L-type Ca2+ channels.

Authors:  J Mitterdorfer; M Grabner; R L Kraus; S Hering; H Prinz; H Glossmann; J Striessnig
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

9.  Dapagliflozin reduces the amplitude of shortening and Ca(2+) transient in ventricular myocytes from streptozotocin-induced diabetic rats.

Authors:  N N Hamouda; V Sydorenko; M A Qureshi; J M Alkaabi; M Oz; F C Howarth
Journal:  Mol Cell Biochem       Date:  2014-10-29       Impact factor: 3.396

Review 10.  Molecular pharmacology of high voltage-activated calcium channels.

Authors:  Clinton J Doering; Gerald W Zamponi
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.